Clinical Trial Update: Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the use of sugammadex at the end of general anesthesia shows completed results as of 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia General
• General Anesthesia Complications

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 3 | Status: COMPLETED | Results posted: 2019-03-15